Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 12.37 Billion JPY | 68.82% |
| 2022 | 7.32 Billion JPY | 68.13% |
| 2021 | 4.35 Billion JPY | 7.08% |
| 2020 | 4.07 Billion JPY | 0.98% |
| 2019 | 4.03 Billion JPY | 11.99% |
| 2018 | 3.59 Billion JPY | -44.09% |
| 2017 | 6.43 Billion JPY | -7.55% |
| 2016 | 6.96 Billion JPY | -4.78% |
| 2015 | 7.31 Billion JPY | -3.66% |
| 2014 | 7.59 Billion JPY | 41.51% |
| 2013 | 5.36 Billion JPY | 20.53% |
| 2012 | 4.45 Billion JPY | -26.83% |
| 2011 | 6.08 Billion JPY | -18.68% |
| 2010 | 7.48 Billion JPY | -5.88% |
| 2009 | 7.94 Billion JPY | 1.59% |
| 2008 | 7.82 Billion JPY | -4.8% |
| 2007 | 8.21 Billion JPY | 23.0% |
| 2006 | 6.68 Billion JPY | 15.04% |
| 2005 | 5.8 Billion JPY | 30.87% |
| 2004 | 4.43 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 14.05 Billion JPY | 13.61% |
| 2023 Q4 | 12.37 Billion JPY | 3.67% |
| 2023 Q2 | 10 Billion JPY | 20.18% |
| 2023 Q1 | 8.32 Billion JPY | 13.57% |
| 2023 Q3 | 11.93 Billion JPY | 19.31% |
| 2023 FY | 12.37 Billion JPY | 68.82% |
| 2022 Q3 | 8.09 Billion JPY | 11.35% |
| 2022 Q2 | 7.27 Billion JPY | 47.72% |
| 2022 Q1 | 4.92 Billion JPY | 12.96% |
| 2022 FY | 7.32 Billion JPY | 68.13% |
| 2022 Q4 | 7.32 Billion JPY | -9.51% |
| 2021 Q4 | 4.35 Billion JPY | 2.61% |
| 2021 Q2 | 4.3 Billion JPY | 0.11% |
| 2021 Q1 | 4.3 Billion JPY | 5.71% |
| 2021 FY | 4.35 Billion JPY | 7.08% |
| 2021 Q3 | 4.24 Billion JPY | -1.39% |
| 2020 Q3 | 4.18 Billion JPY | 3.35% |
| 2020 Q1 | 4.19 Billion JPY | 4.11% |
| 2020 Q2 | 4.05 Billion JPY | -3.43% |
| 2020 FY | 4.07 Billion JPY | 0.98% |
| 2020 Q4 | 4.07 Billion JPY | -2.82% |
| 2019 Q3 | 4.21 Billion JPY | -0.1% |
| 2019 FY | 4.03 Billion JPY | 11.99% |
| 2019 Q1 | 4.16 Billion JPY | 15.71% |
| 2019 Q2 | 4.21 Billion JPY | 1.29% |
| 2019 Q4 | 4.03 Billion JPY | -4.35% |
| 2018 FY | 3.59 Billion JPY | -44.09% |
| 2018 Q3 | 3.74 Billion JPY | -0.49% |
| 2018 Q2 | 3.76 Billion JPY | -42.1% |
| 2018 Q1 | 6.5 Billion JPY | 1.06% |
| 2018 Q4 | 3.59 Billion JPY | -3.99% |
| 2017 Q4 | 6.43 Billion JPY | -4.61% |
| 2017 Q3 | 6.75 Billion JPY | -3.98% |
| 2017 Q2 | 7.03 Billion JPY | 1.21% |
| 2017 Q1 | 6.94 Billion JPY | -0.28% |
| 2017 FY | 6.43 Billion JPY | -7.55% |
| 2016 Q1 | 7.57 Billion JPY | 3.51% |
| 2016 Q2 | 7.55 Billion JPY | -0.26% |
| 2016 FY | 6.96 Billion JPY | -4.78% |
| 2016 Q4 | 6.96 Billion JPY | -6.7% |
| 2016 Q3 | 7.46 Billion JPY | -1.15% |
| 2015 Q1 | 6.91 Billion JPY | -8.97% |
| 2015 Q3 | 7.29 Billion JPY | -1.52% |
| 2015 Q2 | 7.41 Billion JPY | 7.23% |
| 2015 FY | 7.31 Billion JPY | -3.66% |
| 2015 Q4 | 7.31 Billion JPY | 0.23% |
| 2014 Q3 | 6.9 Billion JPY | 12.84% |
| 2014 FY | 7.59 Billion JPY | 41.51% |
| 2014 Q4 | 7.59 Billion JPY | 9.92% |
| 2014 Q1 | 5.79 Billion JPY | 7.98% |
| 2014 Q2 | 6.12 Billion JPY | 5.67% |
| 2013 Q3 | 5.37 Billion JPY | 9.29% |
| 2013 Q2 | 4.91 Billion JPY | 8.8% |
| 2013 Q1 | 4.51 Billion JPY | 1.51% |
| 2013 FY | 5.36 Billion JPY | 20.53% |
| 2013 Q4 | 5.36 Billion JPY | -0.15% |
| 2012 Q1 | 6.06 Billion JPY | -0.37% |
| 2012 Q4 | 4.45 Billion JPY | -23.97% |
| 2012 Q3 | 5.85 Billion JPY | -7.96% |
| 2012 Q2 | 6.36 Billion JPY | 4.95% |
| 2012 FY | 4.45 Billion JPY | -26.83% |
| 2011 Q4 | 6.08 Billion JPY | -21.56% |
| 2011 Q3 | 7.75 Billion JPY | -7.81% |
| 2011 Q2 | 8.41 Billion JPY | 5.29% |
| 2011 Q1 | 7.99 Billion JPY | 6.8% |
| 2011 FY | 6.08 Billion JPY | -18.68% |
| 2010 FY | 7.48 Billion JPY | -5.88% |
| 2010 Q1 | 8.5 Billion JPY | 7.01% |
| 2010 Q2 | 8.12 Billion JPY | -4.49% |
| 2010 Q3 | 8.1 Billion JPY | -0.22% |
| 2010 Q4 | 7.48 Billion JPY | -7.72% |
| 2009 Q4 | 7.94 Billion JPY | -2.71% |
| 2009 FY | 7.94 Billion JPY | 1.59% |
| 2009 Q3 | 8.17 Billion JPY | 5.2% |
| 2009 Q2 | 7.76 Billion JPY | 0.0% |
| 2008 FY | 7.82 Billion JPY | -4.8% |
| 2008 Q4 | 7.82 Billion JPY | -12.51% |
| 2008 Q3 | 8.94 Billion JPY | 0.0% |
| 2007 FY | 8.21 Billion JPY | 23.0% |
| 2006 FY | 6.68 Billion JPY | 15.04% |
| 2005 FY | 5.8 Billion JPY | 30.87% |
| 2004 FY | 4.43 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| DNA Chip Research Inc. | 67.72 Million JPY | -18169.735% |
| Cosmo Bio Company,Limited | 1.03 Billion JPY | -1092.021% |
| H.U. Group Holdings, Inc. | 22.46 Billion JPY | 44.913% |
| FALCO HOLDINGS Co., Ltd. | 1.46 Billion JPY | -744.009% |
| BML, Inc. | 4.58 Billion JPY | -169.803% |
| Human Metabolome Technologies, Inc. | 36.99 Million JPY | -33350.062% |
| Precision System Science Co., Ltd. | 1.69 Billion JPY | -630.017% |